Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Interest Expenses (2016 - 2023)

Creative Medical Technology Holdings has reported Interest Expenses over the past 13 years, most recently at $50.0 for Q1 2023.

  • Quarterly Interest Expenses changed N/A to $50.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $50.0 through Dec 2023, changed N/A year-over-year, with the annual reading at $4.3 million for FY2021, 247.96% up from the prior year.
  • Interest Expenses was $50.0 for Q1 2023 at Creative Medical Technology Holdings, down from $2.4 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $2.4 million in Q4 2021 and troughed at $50.0 in Q1 2023.
  • The 4-year median for Interest Expenses is $336076.0 (2021), against an average of $569507.8.
  • Biggest five-year swings in Interest Expenses: tumbled 45.35% in 2020 and later skyrocketed 652.38% in 2021.
  • Tracing CELZ's Interest Expenses over 4 years: stood at $407544.0 in 2019, then dropped by 21.64% to $319354.0 in 2020, then skyrocketed by 652.38% to $2.4 million in 2021, then crashed by 100.0% to $50.0 in 2023.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $50.0, $2.4 million, and $1.3 million for Q1 2023, Q4 2021, and Q3 2021 respectively.